Terms: = Bone cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Staging
7 results:
1. Intraductal Prostate cancer Affinity for Lymphatic-Predominant Metastases Through
Bernardino R; Sayyid RK; Lajkosz K; Al-Daqqaq Z; Tiwari R; Cockburn J; Leão R; Metser U; Berlin A; van der Kwast T; Fleshner NE
J Urol; 2024 Apr; 211(4):586-593. PubMed ID: 38299501
[TBL] [Abstract] [Full Text] [Related]
2. A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Bhaludin BN; Tunariu N; Koh DM; Messiou C; Okines AF; McGrath SE; Ring AE; Parton MM; Sharma B; Gagliardi T; Allen SD; Pope R; Johnston SRD; Downey K
Eur Radiol; 2022 Sep; 32(9):6514-6525. PubMed ID: 35384456
[TBL] [Abstract] [Full Text] [Related]
3. bone turnover markers in women with early stage breast cancer who developed bone metastases. A prospective study with multivariate logistic regression analysis of accuracy.
Lumachi F; Basso SM; Camozzi V; Tozzoli R; Spaziante R; Ermani M
Clin Chim Acta; 2016 Sep; 460():227-30. PubMed ID: 27404457
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of 18F-FDG PET/CT for Systemic staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract] [Full Text] [Related]
5. Solitary bone plasmacytoma and extramedullary plasmacytoma.
Dimopoulos MA; Hamilos G
Curr Treat Options Oncol; 2002 Jun; 3(3):255-9. PubMed ID: 12057071
[TBL] [Abstract] [Full Text] [Related]
6. Primary lymphoma of bone: long term results in patients treated with vincristine--adriamycin--cyclophosphamide and local radiation.
Bacci G; Ferraro A; Casadei R; Barbieri E; Avella M; Ferrari S; Bertoni F; Picci P; Ruggieri P; Biagini R
J Chemother; 1991 Jun; 3(3):189-93. PubMed ID: 1919658
[TBL] [Abstract] [Full Text] [Related]
7. High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung.
Cunningham D; Banham SW; Hutcheon AH; Dorward A; Ahmedzai S; Tansey P; Soukop M; Stevenson RD; Stack BR; Kaye SB
Cancer Chemother Pharmacol; 1985; 15(3):303-6. PubMed ID: 2996799
[TBL] [Abstract] [Full Text] [Related]
